Pediatric endocrinology

Drivers of Patient and Caregiver Preferences for Growth Hormone Deficiency Treatments in France: A Discrete Choice Experiment

Horm Res PaediatrPublished Discrete choice experiment

Authors' conclusion

Children with GHD and their caregivers prefer a less frequent injection schedule and lower injection pain. Both aspects of treatment modalities are important to consider in treatment decisions to alleviate the daily burden for GHD patients and their families and potentially enhance treatment adherence.

Study context

Population
French children and adolescents with growth hormone deficiency (GHD) and their caregiverspatients represented
Participants
105 children
Comparison
Autonomous adolescents vs Nonautonomous adolescent/caregiver dyads vs Caregivers of nonautonomous children vs Autonomous children/caregiver dyads
Outcome
Drivers of preference and relative importance of GHD treatment modality attributes (frequency of administration, injection pain, dose setting, type of device, storage, device reusability)
Methodological detailsonline questionnaire, 12 choice tasks, pilot tested, multinomial logit model with random effects
  • Online questionnaire
  • 12 choice tasks
  • Pilot tested
  • Multinomial logit model with random effects

Main finding

As reported in the abstract

Relative importance of treatment attributes
  • Frequency of administration and injection pain had the greatest influence on preferences, with similar importance
  • Weekly administration significantly preferred over daily by all groups
  • Choices also significantly influenced by type of device, dose setting and device reusability

Original publication

Drivers of Patient and Caregiver Preferences for Growth Hormone Deficiency Treatments in France: A Discrete Choice Experiment. Horm Res Paediatr. Published 29 November 2023. doi:10.1159/000534974

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.